Risk of hospitalization with peptic ulcer disease or gastrointestinal hemorrhage associated with nabumetone, Arthrotec®, diclofenac, and naproxen in a population based cohort study

Journal of Rheumatology

Volumn 32, Issue 11, 2005, Pages 2212-2217

  Ashworth, Nigel L ^a   Peloso, Paul M ^b,c   Muhajarine, Nazeem ^d,e   Stang, Maryrose ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b Department of Internal Medicine ^*  (Canada)

^c UNIVERSITY OF IOWA HEALTH CARE   (United States)

^d UNIVERSITY OF SASKATCHEWAN   (Canada)

^e UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Arthrotec; Diclofenac; Gastrointestinal hemorrhage; Nonsteroidal antiinflammatory drugs; Peptic ulcer disease

Indexed keywords

ARTHROTEC; DICLOFENAC; HISTAMINE H2 RECEPTOR ANTAGONIST; MISOPROSTOL; NABUMETONE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR; SUCRALFATE;

ADULT; AGED; ARTICLE; CANADA; COHORT ANALYSIS; DRUG EFFICACY; FEMALE; GASTROINTESTINAL HEMORRHAGE; HOSPITALIZATION; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PEPTIC ULCER; POPULATION RISK; PRESCRIPTION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BUTANONES; COHORT STUDIES; DATABASES, FACTUAL; DICLOFENAC; DRUG COMBINATIONS; FEMALE; GASTROINTESTINAL HEMORRHAGE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; MISOPROSTOL; NAPROXEN; PEPTIC ULCER; RISK FACTORS; SASKATCHEWAN;

EID: 27744548881     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Bloor KM. Is there scope for improving the cost-effective prescribing of NSAIDs? PharmacoEconomics 1996;9:484-96.
2. Gabriel SE, Fehring RA. Trends in the utilization of non-steroidal anti-inflammatory drugs in the United States, 1986-1990. J Clin Epidemiol 1992;45:1041-4.
3. Garcia-Rodriguez LA, Perez Gutthann S, Walker AM, Lueck L. The role of NSAIDs in hospitalizations for acute liver injury in Saskatchewan, BMJ 1992;305:865-8.
4. Carson JL, Strom BL, Duff A, Gupta A, Das K. Safety of NSAIDs with respect to acute liver disease. Arch Intern Med 1993;153:1331-6.
5. Garcia-Rodriguez LA, Williams R, Derby LE, Dean AD, Jick H. Acute liver injury associated with NSAIDs and the role of risk factors. Arch Intern Med 1994;154:311-6.
6. Perneger TV, Whelton PK, Klag MJ. Risk of kidney failure associated with the use of acetaminophen, aspirin and NSAIDs. N Engl J Med 1994;331:1675-9.
7. Perez Gutthann S, Garcia-Rodriguez LA, Raiford DS, Duque Oliart A, Ris Romeu J. NSAIDs and the risk of hospitalization for acute renal failure. Arch Intern Med 1996;156:2433-9.
8. Heerdink ER, Leufkens HG, Herings RM, Ottervanger JP, Stricker BH, Bakker A. NSAIDs associated with increased risk of congestive heart failure in elderly patients taking diuretics. Ann Intern Med 1998;158:1108-12.
9. Quiralte J, Blanco C, Castillo R, Ortega N, Carrillo T. Anaphylactoid reactions due to nonsteroidal antiinflammatory drugs: clinical and cross-reactivity studies. Ann Allergy Asthma Immunol 1997;78:293-6.
10. Melillo G, Padovano A, Masi C, Melillo E, Cocco G. Aspirin-induced asthma and bronchial hyperresponsiveness. Allerg Immunol Paris 1991;23:423-7.
11. Hamerschlak N, Montezuma MP, Bacal N, Szterling LN, Rosenfeld LG, Guerra CC. Retrospective prevalence and incidence of drug-induced agranulocytosis in the city of Sao Paulo-Brasil. Rev Paul Med 1993;111:294-8.
12. Raskin JB. Gastrointestinal effects of nonsteroidal anti-inflammatory therapy. Am J Med 1999;31:3S-12S.
13. Lanas A. Non-steroidal anti-inflammatory drugs and gastrointestinal bleeding. J Gastroenterol Hepatol 1999;31 Suppl:S37-S42.
14. Langman MJ. Epidemiology of non-steroidal anti-inflammatory drug damage to stomach and duodenum. Ital J Gastroenterol Hepatol 1999;31 Suppl:S2-S5.
15. Wolfe MM, Lichtenstein DR, Singh G. Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. N Engl J Med 1999;340:1888-99.
16. McCarthy D. Nonsteroidal anti-inflammatory drug-related gastrointestinal toxicity: definitions and epidemiology. Am J Med 1998;105:3S-9S.
17. Gabriel SE, Jaakkimainen L, Bombardier C. Risk for serious gastrointestinal complications related to use of NSAIDs. A meta-analysis. Ann Intern Med 1991;115:787-96.
18. Griffin MR, Piper JM, Daugherty JR, Snowden M, Ray WA. NSAID use and increased risk for peptic ulcer disease in elderly persons. Ann Intern Med 1991;114:257-63.
19. Phillips AC, Polisson RP, Simon LS. NSAIDs and the elderly. Toxicity and economic implications. Drugs Aging 1997;10:119-30.
20. Lee M, Feldman M. The aging stomach: implications for NSAID gastropathy. Gut 1997;41:425-6.
21. Tenenbaum J. The epidemiology of NSAIDs. Can J Gastroenterol 1999;13:119-22.
22. Silverstein FE, Graham DY, Senior JR, et al. Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1995;123:241-9.
23. Rostom A, Wells G, Tugwell P, Welch V, Dube C, McGowan J. The prevention of chronic NSAID induced upper gastrointestinal toxicity: a Cochrane Collaboration metaanalysis of randomized controlled trials. J Rheumatol 2000;27:2203-14.
24. Scott DL, Palmer RH. Safety and efficacy of nabumetone in osteoarthritis: emphasis on gastrointestinal safety. Aliment Pharmacol Ther 2000;14:443-52.
25. Dieppe P, Bartlett C, Davey P, Doyal L, Ebrahim S. Balancing benefits and harms: the example of non-steroidal anti-inflammatory drugs. BMJ 2004;329:31-4.
26. Ashworth NL, Peloso PM, Muhajarine N, Stang M. A population based historical cohort study of the mortality associated with nabumetone, Arthrotec, diclofenac, and naproxen. J Rheumatol 2004;31:951-6.
27. Downey W, Beck P, McNutt M, Stang MR, Osei W, Nichol J. Health databases in Saskatchewan. In: Strom BL, editor. Pharmacoepidemiology. Chichester: Wiley; 2000:325-45.
28. West SL, Richter A, Melfi CA, McNutt M, Nennstiel ME, Mauskopf JA. Assessing the Saskatchewan database for outcomes research studies of depression and its treatment. J Clin Epidemiol 2000;53:823-31.
29. Rawson NS, Malcolm E, D'Arcy C. Reliability of the recording of schizophrenia and depressive disorder in the Saskatchewan health care datafiles. Soc Psychiatry Psychiatr Epidemiol 1997;32:191-9.
30. Rawson NS, Malcolm E. Validity of the recording of ischaemic heart disease and chronic obstructive pulmonary disease in the Saskatchewan health care datafiles. Stat Med 1995;14:2627-43.
31. de Melo Gomes JA. The safety of Arthrotec in patients with rheumatoid arthritis or osteoarthritis: an assessment of the upper gastrointestinal tract by endoscopy. Scand J Rheumatol Suppl 1992;96:23-31.
32. Langman MJ, Weil J, Wainwright P, et al. Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994;343:1075-8.
33. Hosmer DW, Lemeshow S. Assessing the fit of the model. In: Hosmer DW, Lemeshow S, editors. Applied logistic regression. New York: John Wiley & Sons; 1989:135-75.